On-demand webinar featuring Dr Racha Majed, Technical Sales Specialist, Refeyn

Zeno interrupts the dimerization of HER2 and HER3 and prevents NRG1/HER3 tumour signalling.

Rare disease BPAN currently has no treatment options, this new research investigates whether antisense oligonucleotide therapies could be the answer to address this unmet need.

Oligo sequencing revolutionizes biologics research, ensuring accurate analysis of oligonucleotides. Biologics by Oxford Global explores methods, safety, sustainability, and future trends. Despite challenges, advancements promise exciting opportunities for scientific discovery.

Can oligonucleotide therapeutics shape the future of healthcare? We journey through AI frontiers, sustainable synthesis, and regulatory challenges.

Read how innovators are transforming the industry towards one that prioritizes both healthy patients and a healthy planet.

Recombinant and chemical peptide synthesis methods both have use cases in modern peptide production. Today the industry is looking to sustainable approaches to both.

Sustainable peptide synthesis refers to the development and implementation of methods that minimize the environmental impact of peptide manufacturing while maintaining high efficiency and yield.

Mechanochemical synthesis could unlock new pathways for obtaining peptides in a sustainable and ecologically friendly way.

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

How do things stand with sustainability in pharmaceutical manufacture at present? What are some members of the industry doing to reduce their carbon footprint?

The preclinical peptide could unlock much needed treatment options for patients with triple-negative breast cancer.